Could it be that lobbyists from large pharmaceutical companies are putting pressure on the government to prevent the Israeli medical cannabis market from taking off?
Israel’s attitude toward medical cannabis is schizophrenic.
On one hand, it is probably the most developed nation in the world when it comes to innovation in the field. Israel, one of the few countries where it is completely legal to engage in clinical research, has develop new and innovative ways to deliver the medicinal substance in cannabis. Inhalers, creams, pills and oils make it easier for people who need cannabis to administer it. And researchers have perfected measurement of dosages so that the patient receives the exact amount he or she needs, and is not dependent on fluctuating qualities.